Mackenzie Financial’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $91.9M | Buy |
3,274,513
+165,638
| +5% | +$4.41M | 0.11% | 163 |
|
|
2025
Q4 | $77.5M | Buy |
3,108,875
+2,231
| +0.1% | +$56.3K | 0.09% | 186 |
|
|
2025
Q3 | $79.2M | Buy |
3,106,644
+1,691,773
| +120% | +$41.8M | 0.1% | 183 |
|
|
2025
Q2 | $34.3M | Buy |
1,414,871
+570,408
| +68% | +$13.3M | 0.04% | 286 |
|
|
2025
Q1 | $21.4M | Buy |
844,463
+194,550
| +30% | +$5.09M | 0.03% | 331 |
|
|
2024
Q4 | $17.2M | Sell |
649,913
-96,575
| -13% | -$2.62M | 0.02% | 377 |
|
|
2024
Q3 | $21.6M | Sell |
746,488
-144,630
| -16% | -$4.22M | 0.03% | 333 |
|
|
2024
Q2 | $24.9M | Sell |
891,118
-893,578
| -50% | -$24.6M | 0.04% | 296 |
|
|
2024
Q1 | $49.5M | Buy |
1,784,696
+67,795
| +4% | +$1.88M | 0.07% | 221 |
|
|
2023
Q4 | $49.4M | Buy |
1,716,901
+488,479
| +40% | +$14.8M | 0.07% | 214 |
|
|
2023
Q3 | $41.6M | Sell |
1,228,422
-315,726
| -20% | -$11.2M | 0.07% | 224 |
|
|
2023
Q2 | $56.6M | Buy |
1,544,148
+163,225
| +12% | +$6.35M | 0.09% | 197 |
|
|
2023
Q1 | $56.3M | Sell |
1,380,923
-66,163
| -5% | -$2.86M | 0.09% | 205 |
|
|
2022
Q4 | $74.1M | Sell |
1,447,086
-135,151
| -9% | -$6.48M | 0.12% | 161 |
|
|
2022
Q3 | $69.2M | Buy |
1,582,237
+19,396
| +1% | +$943K | 0.12% | 174 |
|
|
2022
Q2 | $81.9M | Buy |
1,562,841
+225,423
| +17% | +$11.5M | 0.13% | 161 |
|
|
2022
Q1 | $69.2M | Buy |
1,337,418
+79,887
| +6% | +$4.15M | 0.09% | 195 |
|
|
2021
Q4 | $74.3M | Sell |
1,257,531
-113,211
| -8% | -$5.61M | 0.1% | 200 |
|
|
2021
Q3 | $59M | Buy |
1,370,742
+105,161
| +8% | +$4.66M | 0.08% | 213 |
|
|
2021
Q2 | $49.6M | Sell |
1,265,581
-206,251
| -14% | -$8.02M | 0.07% | 225 |
|
|
2021
Q1 | $53.3M | Buy |
1,471,832
+514,496
| +54% | +$18.3M | 0.08% | 201 |
|
|
2020
Q4 | $35.2M | Sell |
957,336
-18,578
| -2% | -$681K | 0.08% | 205 |
|
|
2020
Q3 | $34M | Sell |
975,914
-190,310
| -16% | -$6.67M | 0.08% | 200 |
|
|
2020
Q2 | $36.2M | Sell |
1,166,224
-123,817
| -10% | -$4.21M | 0.1% | 193 |
|
|
2020
Q1 | $40M | Buy |
1,290,041
+618,908
| +92% | +$21.1M | 0.13% | 172 |
|
|
2019
Q4 | $24.9M | Sell |
671,133
-118,085
| -15% | -$4.21M | 0.06% | 229 |
|
|
2019
Q3 | $26.9M | Sell |
789,218
-48,711
| -6% | -$1.77M | 0.07% | 217 |
|
|
2019
Q2 | $34.4M | Sell |
837,929
-1,057,554
| -56% | -$42M | 0.09% | 200 |
|
|
2019
Q1 | $76.4M | Sell |
1,895,483
-1,792,120
| -49% | -$71.8M | 0.18% | 132 |
|
|
2018
Q4 | $153M | Buy |
3,687,603
+424,540
| +13% | +$17.6M | 0.4% | 67 |
|
|
2018
Q3 | $136M | Sell |
3,263,063
-1,676,561
| -34% | -$64.5M | 0.33% | 84 |
|
|
2018
Q2 | $170M | Sell |
4,939,624
-3,192,023
| -39% | -$109M | 0.43% | 59 |
|
|
2018
Q1 | $274M | Sell |
8,131,647
-3,970,368
| -33% | -$136M | 0.7% | 33 |
|
|
2017
Q4 | $416M | Buy |
12,102,015
+12,060,661
| +29,164% | +$411M | 1% | 20 |
|
|
2017
Q3 | $1.4M | Sell |
41,354
-28,733
| -41% | -$923K | 0.01% | 420 |
|
|
2017
Q2 | $2.23M | Buy |
70,087
+7,758
| +12% | +$245K | 0.01% | 379 |
|
|
2017
Q1 | $2.02M | Sell |
62,329
-901,123
| -94% | -$28.4M | 0.01% | 396 |
|
|
2016
Q4 | $29.7M | Sell |
963,452
-27,938
| -3% | -$853K | 0.18% | 150 |
|
|
2016
Q3 | $31.9M | Sell |
991,390
-255,506
| -20% | -$8.54M | 0.2% | 129 |
|
|
2016
Q2 | $41.7M | Buy |
1,246,896
+6,302
| +0.5% | +$201K | 0.24% | 110 |
|
|
2016
Q1 | $34.9M | Buy |
1,240,594
+344,668
| +38% | +$9.85M | 0.32% | 77 |
|
|
2015
Q4 | $27.4M | Buy |
895,926
+379,560
| +74% | +$11.9M | 0.17% | 136 |
|
|
2015
Q3 | $15.4M | Sell |
516,366
-35,467
| -6% | -$1.14M | 0.09% | 203 |
|
|
2015
Q2 | $17.6M | Buy |
551,833
+33,673
| +6% | +$1.1M | 0.1% | 198 |
|
|
2015
Q1 | $17.1M | Buy |
518,160
+51,826
| +11% | +$1.65M | 0.09% | 204 |
|
|
2014
Q4 | $13.8M | Buy |
466,334
+282,209
| +153% | +$8.09M | 0.07% | 213 |
|
|
2014
Q3 | $5.17M | Sell |
184,125
-775,380
| -81% | -$21.8M | 0.03% | 307 |
|
|
2014
Q2 | $27M | Sell |
959,505
-82,103
| -8% | -$2.34M | 0.13% | 155 |
|
|
2014
Q1 | $31.7M | Buy |
1,041,608
+287,745
| +38% | +$8.58M | 0.16% | 137 |
|
|
2013
Q4 | $21.9M | Sell |
753,863
-1,242,531
| -62% | -$36.2M | 0.11% | 178 |
|
|
2013
Q3 | $54.4M | Sell |
1,996,394
-1,650,598
| -45% | -$44.9M | 0.28% | 81 |
|
|
2013
Q2 | $96.9M | Buy |
+3,646,992
| New | +$101M | 0.46% | 63 |
|
Other funds holding PFE
VCM
VPM
Mackenzie Financial's PFE Position: Q1 2026 in Review
Mackenzie Financial increased its Pfizer (PFE) stake by 5.3% in Q1 2026, buying an estimated $4.41M and bringing the position to 3,274,513 shares worth $91.9M. The position accounts for 0.11% of the portfolio, ranked #163.
Mackenzie Financial first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $416M in Q4 2017. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Mackenzie Financial held 3,274,513 shares of Pfizer worth $91.9M as of Q1 2026.
- Mackenzie Financial bought 165,638 Pfizer shares in Q1 2026, an estimated $4.41M.
- Pfizer made up 0.11% of Mackenzie Financial's portfolio in Q1 2026, its #163 holding.
- Mackenzie Financial first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Mackenzie Financial's Pfizer position peaked at $416M in Q4 2017.
- 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Mackenzie Financial's 13F filing for Q1 2026, filed 13 May 2026.